Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.

Giacchetti S, Laas E, Bachelot T, Lemonnier J, André F, Cameron D, Bliss J, Chabaud S, Hardy-Bessard AC, Lacroix-Triki M, Canon JL, Debled M, Campone M, Cottu P, Dalenc F, Ballesta A, Penault-Llorca F, Asselain B, Dumas E, Reyal F, Gougis P, Lévi F, Hamy AS

Open source

DOI: 10.1016/j.ebiom.2024.105141
Published: 2024 Jun
Container: EBioMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2024.105141,
  title = {Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.},
  author = {Giacchetti S and Laas E and Bachelot T and Lemonnier J and André F and Cameron D and Bliss J and Chabaud S and Hardy-Bessard AC and Lacroix-Triki M and Canon JL and Debled M and Campone M and Cottu P and Dalenc F and Ballesta A and Penault-Llorca F and Asselain B and Dumas E and Reyal F and Gougis P and Lévi F and Hamy AS},
  year = {2024},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2024.105141},
  url = {https://doi.org/10.1016/j.ebiom.2024.105141}
}

RIS

TY  - JOUR
TI  - Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.
AU  - Giacchetti S
AU  - Laas E
AU  - Bachelot T
AU  - Lemonnier J
AU  - André F
AU  - Cameron D
AU  - Bliss J
AU  - Chabaud S
AU  - Hardy-Bessard AC
AU  - Lacroix-Triki M
AU  - Canon JL
AU  - Debled M
AU  - Campone M
AU  - Cottu P
AU  - Dalenc F
AU  - Ballesta A
AU  - Penault-Llorca F
AU  - Asselain B
AU  - Dumas E
AU  - Reyal F
AU  - Gougis P
AU  - Lévi F
AU  - Hamy AS
PY  - 2024
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2024.105141
UR  - https://doi.org/10.1016/j.ebiom.2024.105141
ER  -

APA

S, G., E, L., T, B., J, L., F, A., D, C., J, B., S, C., AC, H., M, L., JL, C., M, D., M, C., P, C., F, D., A, B., F, P., B, A., E, D., F, R., P, G., F, L., & AS, H. (2024). Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105141

Source records

pubmed · retrieved 2026-09-26T02:22:44.762Z